Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

Blueprint Medicines (BPMC) shares ended the last trading session 18.2% higher at $103.36. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Barclays analyst Peter Lawson maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report) today and set a price target of $31.00.

A hospital in central Taiwan has reported three new measles cases in a cluster infection, bringing the total number in the local outbreak to 19, with 36 cases reported in the country so far this year.

Cade Cunningham leading Pistons back to relevancy Detroit is relevant in basketball circles again and Cade Cunningham is a ...

ETFs One of the easiest ways for Main Street investors to own alts is through a mutual fund or exchange-traded fund (ETF). They trade daily, which solves the liquidity problem, but experts say that ...

Many of Donald Trump's Cabinet picks have been meeting with senators individually. Now, they'll go this week before the ...

Though the governor promised to make Illinois “the best state” to raise young children, child care continues to disappear.

New Jersey is going to build up a supply of medication used in abortions, Democratic Gov. Phil Murphy announced Tuesday ...

“His legacy lives on because his barbershop is still there. But, we remember Toney as the icon of Palm Coast,” said Esther Hamilton, pre- siding during the reflections at Toney’s funeral, a huge ...